Scholar Rock (NASDAQ:SRRK) executives said the company is “poised for a transformative year in 2026,” with its top priority centered on resubmitting the biologics license application (BLA) for apitegr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results